📰 Anthonym Hunter News
Anthonym Hunter News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Anthonym Hunter. Real-time updates on events, politics, business and more.
October 26, 2023
Anthony M. Hunter, MD, discusses the evolution of JAK inhibitors in myelofibrosis, a topic that was highlighted in a presentation at the 2023 SOHO Annual Meeting.
October 19, 2023
Anthony M. Hunter, MD, discusses the roles for pacritinib, momelotinib, and fedratinib in patients with myelofibrosis; treatment sequencing with newer-generation JAK inhibitors after ruxolitinib; and the importance of having several treatment options in the second-line setting and beyond.
September 12, 2023
"We are thankfully starting to be blessed with more options than weve ever had," but "in the frontline proliferative setting, ruxolitinib has remained the standard of care."
September 11, 2023
Anthony M Hunter, MD, discusses the current treatment landscape with JAK inhibitors in myelofibrosis.